Chinese Journal of New Drugs 2005 Issue 12 mei ri de guo jia yi yao chuang xin ti xi de bi jiao

mei ri de guo jia yi yao chuang xin ti xi de bi jiao
qu feng hong ; huang tai kang

..............page:1377-1379

cong li ti yi ju tan zhong yao gai ji xing pin zhong
wang hai nan

..............page:1380-1381

zhong yao tong pin zhong bao hu xian zhuang fen xi yu dui ce
chen guang yao ; li xian yuan

..............page:1382-1383

The pharmaceutical prospect of B lymphocyte stimulator
SHI Xiao-juan;MAO Wei-ping

..............page:1384-1387

Advances on the research of targeted drug delivery system for traditional Chinese medicine
HU Lin-feng;LI Shao-ping;WANG Yi-tao

..............page:1387-1390

Pharmacoproteomics in drug development: current status and trends
JIANG Ning;ZHOU Wen-xia;ZHANG Yong-xiang

..............page:1391-1394

Advances in iontophoretic transdermal delivery of peptide and protein drugs
ZHU Yao-liang;LIU Wei;CHEN Hua-bing;YANG Xiang-liang

..............page:1394-1400

Advances on glycoprotein research
ZHONG Na;HAO Lin-hua;WANG Xiao-ru

..............page:1400-1403

Current status of clinical trials for recombinant human interleukin 10
JING Shen-rong;ZOU Quan-ming

..............page:1403-1406

kou fu yi ji zuo yuan mei bing yi dao su wai yong zhi liao tang niao bing zu kui yang de liao xiao
wang gui zhen ; ma bao yu ; jiang shao rong

..............page:1479-1480

Synthesis of felbamate
ZHAO Dong-mei;LIU Yao;L(U) Jiu-an;CHENG Mao-sheng

..............page:1443-1444

Synthesis of alfacalcidol
CHEN Yang-sheng;REN Li;ZHAI Cui-yun

..............page:1441-1443

Determination of in-vitro release for sustained-release triptolide tablets by RP-HPLC
WANG Lin;CAI Bao-chang;WANG Shu-dong;LI Wei-dong;HU Min-min

..............page:1438-1440

Preparation of alginate microcapsules
QUAN Ji-shan;CUI Jing-hao;GUO Jian-peng

..............page:1435-1437

Preparation of marine gastro-retentive sustained-release tablets and evaluation of its bioavailability in beagle dogs
YIN Li-fang;HE Dun-wei;WANG Xiao-yang;ZHANG Lu-yong;JIANG Zhen-zhou

..............page:1432-1435

Study on the antihyperlipidemia effect of Xinnaozhibaoping
ZHAO Li;CHEN Zhen;WANG Xia;Guo Qing-long

..............page:1427-1431

Effectiveness of crocin against myocardial injury
DU Peng;QIAN Zhi-yu;SHEN Xiang-chun;RAO Shu-yun;WEN Na

..............page:1423-1427

Anti-inflammatory effect of three statin agents
ZHAO Zheng;WANG Yan-yan;HUANG Feng;REN Jian-ping

..............page:1421-1423

Anti-oxidization of tiopronim in rats with fatty liver
GUO Xiu-li;LI Rui-jun;Yang Zhao-xu

..............page:1417-1421

Tissue distribution of 3- hydroxyandrost 5- en- 17- one succinate (A1998) intralipid after the intravenous injection in rats
ZHANG Tian-yu;ZHANG Guo-liang;BU Xiu-yun;WANG Xin;LOU Ya-qing

..............page:1414-1417

Screening for α-glucosidase inhibitors in natural medicines by immobilized enzyme
LU Da-sheng;L(U) Jing-ci;YONG Ke-lan;CHEN Xu;FENG Si-min;GU Hui-juan

..............page:1411-1414

Aloe spp. in diabetes therapies
WAN Jin-zhi;ZHANG Jun-li;QIAO Yue-xin;WANG Li-da

..............page:1406-1410

Rituximab in the treatment of blood diseases
ZHANG Ji

..............page:1481-1485

The efficacy and safety of the third generation antihistamine desloratadine in clinical use
XU Dao-hua

..............page:1486-1488

Vaniqa
zhang jun

..............page:1488-1489

ding jun sheng
jia zhong wei ; lv xiao ling ; dong zhen xiang

..............page:1489-1490

yao xue jing ying

..............page:1491-1494,1510

2005 nian guo jia shi pin yao pin jian du guan li ju pi zhun de xin yao ( qi )

..............page:1495-1500

ji xu jiao yu

..............page:1501

A Phase Ⅰ clinical trial for recombinant human acidic fibroblast growth factor
XU Hua;ZHENG Qing;WU Xiao-ping;FU Xiao-bing;CAO Zhi-fang;LI Xiao-kun

..............page:1476-1479

A randomized, mutlti-center, double blind and parallel controlled clinical trial for Kuntai capsules in the treatment of climacteric syndromes
CHEN Rong;LIN Shou-qing;YANG Xin;LUAN Yan-qiu;CHEN Ji-ying;CHAI Li-na;ZHANG Ying;JIANG Ying

..............page:1472-1476

Efficacy and safety of omeprazole injection made in China in adults with non-esophagus varicose upper gastrointestinal bleeding.
HU Fu-lian;DONG Xin-hong;CHENG Hong;XIE Peng-yan;HUANG Nai-xia;L(U) Zong-shun;YUAN Yao-zong

..............page:1469-1471

The determination of serum concentrations and pharmakokinetics of mecobalamin using an automated immunoassay chemiluminescent technique
YANG Zhi-fu;WEN Ai-dong;ZHAO Lei;WU Yin;SHEN Tong

..............page:1465-1468

Analysis of the relativity between CYP3A4 genic type and concentration of CsA in renal transplantation patients
WANG Hong;WEN Si-yuan;GUO Dai-hong;PEI Bao-xiang

..............page:1462-1465

Strategies to control confounding factors in clinical trials
XIA Yan;PAN Xiao-ping;NI Zong-zan

..............page:1459-1461

The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data
SUN Kao-xiang

..............page:1454-1459

Quantification of aceglutamide aluminum and its related substances by ion pair chromatography
BIAN Hai-yong;DENG Shu-hai;XU Wen-fang

..............page:1450-1453

HPLC determination of protoberberines in Futai soft capsules
XING Jun-bo;XU Jin-ning;WU He;CAO Hong;LIU Cheng-hong;CHEN Yu-min;LIU Yun

..............page:1448-1450

Quality control for bi-gingers soft capsules
FENG Yi-fan;GUO Xiao-ling;MENG Qing

..............page:1445-1448